Asahi Kasei (TSE:3407) Lands China License And Lifts Guidance, Is It Still Below Fair Value?

Asahi Kasei (TSE:3407) drew fresh attention after announcing its first license agreement in China for Acetolyte electrolyte technology with HighChem Shanghai, alongside recent quarterly results and earnings guidance that give investors more concrete data to assess.

See our latest analysis for Asahi Kasei.

Asahi Kasei's recent China license for Acetolyte, alongside higher dividend guidance and fresh earnings forecasts announced on 31 July 2026, comes after a 1-day share price return of 1.90% and a year to date share price return of 17.32%. The 1-year total shareholder return of 56.61% and 3-year total shareholder return of 96.77% indicate that long term holders have seen stronger gains even though the 30 day share price return declined 11.45%. This suggests momentum has cooled recently.

If this kind of battery and materials story has your attention, it can be useful to scan other related opportunities through the 37 power grid technology and infrastructure stocks

After a sharp rerating over the past year and a recent pullback, Asahi Kasei now sits at a crossroads of upbeat guidance, a China licensing step and cooling short term momentum. Does that balance still favour new buyers on valuation grounds?

Price-to-Earnings of 11.6x: Is it justified?

On Simply Wall St's numbers, Asahi Kasei trades on a P/E of 11.6x, which is framed as offering good value even after the strong share price performance into 2026.

The P/E ratio compares what you pay today for each unit of current earnings. For a diversified materials, homes and healthcare group like Asahi Kasei, this is a straightforward way to relate the current ¥1,666 share price to the earnings power that supports its dividend and reinvestment plans.

Asahi Kasei is flagged as good value versus both peers and its own fair ratio. The current 11.6x P/E is below the estimated fair P/E of 17.4x, and also below the peer average of 56.3x and the broader JP Chemicals industry average of 13.1x. That is a wide gap the market could eventually move toward if earnings quality and growth forecasts are sustained.

Explore the SWS fair ratio for Asahi Kasei

Result: Price-to-Earnings of 11.6x (UNDERVALUED)

However, investors still need to weigh risks such as any setback in China licensing progress or unexpected pressure on Asahi Kasei's net income and revenue trends.

Find out about the key risks to this Asahi Kasei narrative.

Another View on Asahi Kasei's Valuation

The P/E story suggests Asahi Kasei is on the cheap side. The SWS DCF model presents an even stronger case. At ¥1,666 the stock is described as trading 56.8% below an estimated future cash flow value of ¥3,857.64. If that gap persists, what is the market still unsure about?

Look into how the SWS DCF model arrives at its fair value.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Asahi Kasei for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 18 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

If Asahi Kasei's mix of valuation signals and recent news leaves you cautiously optimistic, consider examining the details promptly and pressure testing your own thesis. To see what investors are excited about, review the 5 key rewards

Looking for more investment ideas beyond Asahi Kasei?

If you want to keep making informed moves, do not stop with Asahi Kasei. Use Simply Wall St screeners to surface fresh, data backed opportunities today.

• Target higher potential income by reviewing companies labelled as 43 dividend fortresses that match your comfort level on yield and payout stability.
• Hunt for potential bargains by scanning the 18 high quality undervalued stocks that combine quality fundamentals with prices that still look reasonable.
• Focus on resilience first and review the 56 resilient stocks with low risk scores to spot companies that may better align with a cautious approach.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com